These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Concentration of leptin in patients on hemodialysis and peritoneal dialysis]. Zbroch E; Małyszko J; Wołczyński S; Hryszko T; Myśliwiec M Pol Arch Med Wewn; 1999 Jun; 101(6):503-8. PubMed ID: 10754736 [TBL] [Abstract][Full Text] [Related]
3. Serum concentrations and peritoneal loss of growth hormone and growth-hormone-binding protein activity in older adults undergoing continuous ambulatory peritoneal dialysis: comparison with haemodialysis patients and normal subjects. Kagan A; Zadik Z; Gertler A; Ulman M; Bar-Khayim Y Nephrol Dial Transplant; 1993; 8(4):352-6. PubMed ID: 8390011 [TBL] [Abstract][Full Text] [Related]
4. The effect of continuous ambulatory peritoneal dialysis on change in serum leptin. Kim DJ; Oh DJ; Kim B; Lim YH; Kang WH; Lee BH; Lee SK; Huh W; Kim SE; Lee MK; Kang SA; Oh HY Perit Dial Int; 1999; 19 Suppl 2():S172-5. PubMed ID: 10406513 [TBL] [Abstract][Full Text] [Related]
5. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose. Heimbürger O; Stenvinkel P; Berglund L; Tranoeus A; Lindholm B Nephron; 1996; 72(2):135-44. PubMed ID: 8684516 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the humoral markers of bone turnover and bone mineral density in patients on haemodialysis and continuous ambulatory peritoneal dialysis. Hampson G; Vaja S; Evans C; Chesters CA; Pettit R; Evans W; Thomas D; Seed PT; Fraser WD Nephron; 2002 May; 91(1):94-102. PubMed ID: 12021525 [TBL] [Abstract][Full Text] [Related]
9. Relationship between serum leptin levels and body composition and markers of malnutrition in nondiabetic patients on peritoneal dialysis or hemodialysis. Yilmaz A; Kayardi M; Icagasioglu S; Candan F; Nur N; Gültekin F J Chin Med Assoc; 2005 Dec; 68(12):566-70. PubMed ID: 16379340 [TBL] [Abstract][Full Text] [Related]
10. Serum leptin, resistin, and lipid levels in patients with end stage renal failure with regard to dialysis modality. Taskapan MC; Taskapan H; Sahin I; Keskin L; Atmaca H; Ozyalin F Ren Fail; 2007; 29(2):147-54. PubMed ID: 17365928 [TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor system components in relation to erythropoietin therapy and bone metabolism in dialyzed patients and kidney transplant recipients. Małyszko J; Wołczyński S; Zbroch E; Brzósko S; Małyszko J; Myśliwiec M Nephron; 2002 Mar; 90(3):282-9. PubMed ID: 11867949 [TBL] [Abstract][Full Text] [Related]
12. Peritoneal clearance of leptin in CAPD patients: impact of local insulin administration. Heimbürger O; Wang T; Lönnqvist F; Stenvinkel P Nephrol Dial Transplant; 1999 Mar; 14(3):723-7. PubMed ID: 10193827 [TBL] [Abstract][Full Text] [Related]
14. Leptin in peritoneal dialysate from continuous ambulatory peritoneal dialysis patients. Tsujimoto Y; Shoji T; Tabata T; Morita A; Emoto M; Nishizawa Y; Morii H Am J Kidney Dis; 1999 Nov; 34(5):832-8. PubMed ID: 10561138 [TBL] [Abstract][Full Text] [Related]
15. Plasma and peritoneal endothelin levels and blood pressure in CAPD patients with or without erythropoietin replacement therapy. Lebel M; Moreau V; Grose JH; Kingma I; Langlois S Clin Nephrol; 1998 May; 49(5):313-8. PubMed ID: 9617496 [TBL] [Abstract][Full Text] [Related]
16. Clearance of pentosidine, an advanced glycation end product, by different modalities of renal replacement therapy. Miyata T; Ueda Y; Yoshida A; Sugiyama S; Iida Y; Jadoul M; Maeda K; Kurokawa K; van Ypersele de Strihou C Kidney Int; 1997 Mar; 51(3):880-7. PubMed ID: 9067925 [TBL] [Abstract][Full Text] [Related]
18. Evidence for preservation of cortical bone mineral density in patients on continuous ambulatory peritoneal dialysis. Mottet JJ; Horber FF; Casez JP; Descoeudres C; Jaeger P J Bone Miner Res; 1996 Jan; 11(1):96-104. PubMed ID: 8770702 [TBL] [Abstract][Full Text] [Related]
19. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease. Tuzcu A; Bahceci M; Yilmaz ME; Turgut C; Kara IH Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871 [TBL] [Abstract][Full Text] [Related]
20. Effects of short-term recombinant human growth hormone therapy on plasma leptin concentrations in dialysis patients. Iglesias P; Díez JJ; Fernández-Reyes MJ; Bajo MA; Aguilera A; Méndez J; Codoceo R; Selgas R Nephrol Dial Transplant; 2002 Feb; 17(2):260-4. PubMed ID: 11812876 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]